LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $171,000 | +3.0% | 16,037 | +16.1% | 0.00% | 0.0% |
| Q2 2018 | $166,000 | +40.7% | 13,813 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $118,000 | -15.7% | 13,813 | -2.7% | 0.00% | 0.0% |
| Q4 2017 | $140,000 | -29.3% | 14,201 | -12.0% | 0.00% | -33.3% |
| Q3 2017 | $198,000 | +11.2% | 16,146 | +49.6% | 0.00% | 0.0% |
| Q2 2017 | $178,000 | +6.6% | 10,793 | -7.6% | 0.00% | 0.0% |
| Q1 2017 | $167,000 | +5.7% | 11,677 | +2.5% | 0.00% | 0.0% |
| Q4 2016 | $158,000 | -61.3% | 11,397 | -49.6% | 0.00% | -57.1% |
| Q3 2016 | $408,000 | – | 22,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |